Brand Engagement Network Partners with Global Advertising Agency for AI Engagement Solution

Brand Engagement Network Partners with a Global Ad Agency

Introduction

On December 29, 2025, Brand Engagement Network Inc. (BNAI), a prominent provider of generative AI solutions, announced a significant development in its partnership with a major global advertising agency. This collaboration aims to create a proprietary AI engagement communication method designed for one of the world's leading pharmaceutical companies, which remains unnamed pending a formal release of their innovative solution. This partnership highlights the increasing integration of AI technologies within the healthcare sector.

Details of the Agreement

Under the new Vendor Services Project Agreement, BEN is set to recognize approximately $250,000 in revenue during the fourth quarter of 2025. This revenue will stem from development services outlined in two Statements of Work related to the project. Moreover, BEN anticipates recurring monthly license fees starting in the first quarter of 2026. This step not only strengthens BEN's financial outlook but also indicates a growing demand for AI-driven solutions in the healthcare industry.

Significance of AI in Healthcare

The medical landscape is rapidly evolving, with generative AI playing an influential role in how patients, healthcare providers, and pharmaceutical manufacturers interact. Tyler Luck, the Acting CEO of BEN, remarked on the importance of this agreement, expressing confidence that BEN's technology can deliver secure, trusted, and efficient AI solutions. By focusing on enhancing consumer experiences, BEN aims to meet the needs of healthcare consumers accurately and reliably, reinforcing its role in the healthcare ecosystem.

Expanding Horizons in Latin America

In addition to this partnership, BEN is engaged in a licensing partnership exclusive to Latin America and is set to launch Skye Salud, an AI healthcare platform in Mexico. This ongoing effort aligns with BEN's mission to expand its influence in the healthcare sector across various markets, particularly where there is a pressing need for integration of advanced technologies to improve healthcare delivery.

This strategic move not only aims to enhance the quality of healthcare services but also positions BEN as a pivotal player in the healthcare technology landscape, focusing on secure AI implementations that protect consumer information and foster trust in digital health solutions.

Future Prospects and Company Outlook

The advancements made through this collaboration with the advertising agency and the launch of Skye Salud are anticipated to contribute positively to BEN's fourth-quarter results for 2025. Moreover, as the healthcare industry continues to adopt AI technologies more comprehensively, BEN is optimistic about further growth and expansion opportunities in this vital segment. The partnership with the advertisement agency exemplifies BEN's forward-thinking approach, as it strives to leverage cutting-edge technology within the pharmaceutical field.

For stakeholders and interested parties, more information about this agreement can be accessed through BEN's filings with the Securities and Exchange Commission, specifically the Current Report on Form 8-K submitted on December 29, 2025. Additionally, insights into BEN’s initiatives in Latin America and the Skye Salud platform can be found on the company's investor relations website.

Conclusion

Brand Engagement Network Inc. is setting a precedent in the healthcare industry by forging partnerships that harness the power of generative AI. Its collaboration with a leading global ad agency marks a significant step in utilizing AI to improve communication and engagement in the pharmaceutical sphere. As BEN continues to grow within this space, it is likely to enhance healthcare experiences not just in the U.S. but also throughout Latin America, demonstrating the transformative potential of technology in addressing consumer needs effectively.